Primary record
(1R,3aS,3bR,7Z,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-7-(hydroxyimino)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-ol
- 库存
- 3,360 克
- 纯度
- 98.3 %
- CAS
- 74183-54-3
化合物标识与属性
- CAS
- 74183-54-3
- PubChem CID
- 6537152
- SMILES
- CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C/C(=N\O)/CC[C@H]34
- Canonical SMILES
- C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N\O)CC[C@@H]4[C@H]3CC[C@@]21CC
名称与同义词
- Norelgestromin
- syn-Norelgestromin
- 17-Deacetylnorgestimate
- Levonorgestrel oxime
- Norplant 3-oxime
- ((Z)-Norelgestromin)
- Norelgestromin, (Z)-
- D-Norgestrel 3-oxime
- 17-Deacylnorgestimate
- (Z)-17-Deacetylnorgestimate
- progestin norelgestromin
- 87KQN94RHX
- Levonorgestrel 3-Oxime
- 18-Methylnorethindrone oxime
- E-17-Deacetylnorgestimate
- UNII-87KQN94RHX
- Norgestimate EP Impurity D
- RefChem:202309
- 17-Desacetyl Norgestimate
- 17-Deacetylnorgestimate, (Z)-
- (3E)-17-Deacetylnorgestimate
- Norelgestromin [USAN:INN]
- UNII-R0TAY3X631
- Norgestimate impurity D [EP]
- (3Z)-17-Desacetyl Norgestimate
- SCHEMBL3267125
- C21H29NO2
- Norelgestromin [USAN:INN:BAN]
- BRN 4202099
- ISHXLNHNDMZNMC-VTKCIJPMSA-N
- ZINC3973186
- C21-H29-N-O2
- Norgestimate metabolite Norelgestromin
- RWJ 10553
- NORGESTIMATE IMPURITY D [EP IMPURITY]
- 74183-54-3
- J393.542F
- J968.618E
- NORGESTIMATE IMPURITY D (EP IMPURITY)
- 17-Deacetyl norgestimate;17-Deacylnorgestimate
- EN300-25622248
- 53016-31-2
- 74183-55-4
- (3Z)-13beta-Ethyl-3-(hydroxyimino)-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol
- 18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, OXIME, (3Z,17.ALPHA.)-
- 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (3Z,17alpha)-
- (17|A)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one Oxime
- (17R)-13-Ethyl-17-hydroxy-18,19-dinor-pregna-4-ene-20-yne-3-oneoxime
- (1R,3aS,3bR,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-7-(hydroxyimino)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-ol
- (3Z)-13.BETA.-ETHYL-3-(HYDROXYIMINO)-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-17-OL
- (17R)-17-Hydroxy-13-ethyl-18,19-dinorpregna-4-ene-20-yne-3-one (Z)-oxime
- (3Z,17R)-13beta-Ethyl-17-hydroxy-18,19-dinorpregna-4-ene-20-yne-3-oneoxime
- [17R,(+)]-17-Hydroxy-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one oxime
- [17R,(+)]-17-Hydroxy-13-ethyl-18,19-dinorpregna-4-ene-20-yne-3-oneoxime
- (1R,3aS,3bR,7Z,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-7-(hydroxyimino)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-ol
- (3Z,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
- (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one oxime
- (8R,9S,10R,13S,14S,17R,Z)-13-ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one oxime
- 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (3E,17a)- (9CI); anti-Norelgestromin